Mark J. Millan

发表

Contrasting mechanisms of action and sensitivity to antipsychotics of phencyclidine versus amphetamine: importance of nucleus accumbens 5‐HT2A sites for PCP‐induced locomotion in the rat

M. Millan, A. Gobert, J. Rivet, 1999, The European journal of neuroscience.

Induction of hypothermia as a model of 5-hydroxytryptamine1A receptor-mediated activity in the rat: a pharmacological characterization of the actions of novel agonists and antagonists.

M. Millan, A. Gobert, J. Rivet, 1993, The Journal of pharmacology and experimental therapeutics.

CRF1 receptor antagonists do not reverse pharmacological disruption of prepulse inhibition in rodents

G. Griebel, D. Boulay, L. Groenink, 2013, Psychopharmacology.

A comparative in vitro and in vivo pharmacological characterization of the novel dopamine D3 receptor antagonists (+)-S 14297, nafadotride, GR 103,691 and U 99194.

M. Millan, A. Gobert, J. Rivet, 1998, The Journal of pharmacology and experimental therapeutics.

Functional correlates of dopamine D3 receptor activation in the rat in vivo and their modulation by the selective antagonist, (+)-S 14297: 1. Activation of postsynaptic D3 receptors mediates hypothermia, whereas blockade of D2 receptors elicits prolactin secretion and catalepsy.

C Dacquet, M. Millan, A. Gobert, 1995, The Journal of pharmacology and experimental therapeutics.

Changes in EEG spectral power in the prefrontal cortex of conscious rats elicited by drugs interacting with dopaminergic and noradrenergic transmission

M. Spedding, M. Millan, C. Sebban, 1999, British journal of pharmacology.

Novel benzodioxopiperazines acting as antagonists at postsynaptic 5-HT1A receptors and as agonists at 5-HT1A autoreceptors: a comparative pharmacological characterization with proposed 5-HT1A antagonists.

M. Millan, A. Gobert, J. Rivet, 1994, The Journal of pharmacology and experimental therapeutics.

S 15535: a highly selective benzodioxopiperazine 5-HT1A receptor ligand which acts as an agonist and an antagonist at presynaptic and postsynaptic sites respectively.

M. Millan, A. Gobert, J. Rivet, 1993, European journal of pharmacology.

Stereospecific blockade of marble-burying behaviour in mice by selective, non-peptidergic neurokinin1 (NK1) receptor antagonists

M. Millan, M. Brocco, S. Girardon, 2002, Neuropharmacology.

Modulation of the activity of central serotoninergic neurons by novel serotonin1A receptor agonists and antagonists: a comparison to adrenergic and dopaminergic neurons in rats.

M. Millan, A. Gobert, J. Rivet, 1995, The Journal of pharmacology and experimental therapeutics.

S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: II. Functional and behavioral profile compared with GR218,231 and L741,626.

M. Millan, J. Rivet, G. Lavielle, 2000, The Journal of pharmacology and experimental therapeutics.

The selective serotonin (5-HT)1A receptor ligand, S15535, displays anxiolytic-like effects in the social interaction and Vogel models and suppresses dialysate levels of 5-HT in the dorsal hippocampus of freely-moving rats

M. Millan, A. Gobert, M. Brocco, 2000, Psychopharmacology.

Discriminative stimulus properties of the novel serotonin (5-HT)2C receptor agonist, RO60-0175: a pharmacological analysis

M. Millan, S. Girardon, A. Dekeyne, 1999, Neuropharmacology.

Reciprocal Autoreceptor and Heteroreceptor Control of Serotonergic, Dopaminergic and Noradrenergic on Behalf Of: British Association for Psychopharmacology

M. Millan, A. Gobert, F. Lejeune, 2022 .

[3H]S33084: a novel, selective and potent radioligand at cloned, human dopamine D3 receptors

M. Millan, D. Cussac, A. Newman-Tancredi, 2000, Naunyn-Schmiedeberg's Archives of Pharmacology.

Blockade of the discriminative stimulus effects of DOI by MDL 100,907 and the 'atypical' antipsychotics, clozapine and risperidone.

R. Schreiber, M. Millan, M. Brocco, 1994, European journal of pharmacology.

5-HT1A receptors and the tail-flick response. IV. Spinally localized 5-HT1A receptors postsynaptic to serotoninergic neurones mediate spontaneous tail-flicks in the rat.

M. Millan, J. Rivet, K. Bervoets, 1993, The Journal of pharmacology and experimental therapeutics.

Labelling of recombinant human and native rat serotonin 5-HT1A receptors by a novel, selective radioligand, [3H]-S 15535: Definition of its binding profile using agonists, antagonists and inverse agonists

M. Millan, A. Newman-Tancredi, C. Chaput, 1998, Naunyn-Schmiedeberg's Archives of Pharmacology.

S33084, a novel, potent, selective, and competitive antagonist at dopamine D(3)-receptors: I. Receptorial, electrophysiological and neurochemical profile compared with GR218,231 and L741,626.

M. Millan, D. Cussac, A. Gobert, 2000, The Journal of pharmacology and experimental therapeutics.